Narrative review summarizes bispecific antibodies and CAR T-cell therapy for advanced lung cancer.
New Lung Cancer Tools Are Coming Soon
This narrative review evaluates bispecific antibodies and chimeric antigen receptor (CAR) T-cell therapy for patients with advanced non–smal…
Imagine a soldier who can fight two enemies at once.
Mini-review of phase III trial data on sublobar resection for small peripheral NSCLC
Surgeons Are Removing Less Lung Tissue for Early Cancer—And It Works Just as Well
This mini-review synthesizes findings from a multicenter phase III trial comparing sublobar resection to lobectomy in patients with peripher…
For early-stage lung cancer, removing just a small wedge of tissue offers the same survival rates as taking out a whole lung section.